Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease.
Cheifetz AS, Abreu MT, Afif W, Cross RK, Dubinsky MC, Loftus EV Jr, Osterman MT, Saroufim A, Siegel CA, Yarur AJ, Melmed GY, Papamichael K. Cheifetz AS, et al. Among authors: siegel ca. Am J Gastroenterol. 2021 Oct 1;116(10):2014-2025. doi: 10.14309/ajg.0000000000001396. Am J Gastroenterol. 2021. PMID: 34388143 Free PMC article. Review.
Improving quality of care in IBD: a STEEEP challenge.
Siegel CA, Melmed GY, Ullman TA. Siegel CA, et al. Inflamm Bowel Dis. 2010 Jan;16(1):134-6. doi: 10.1002/ibd.21024. Inflamm Bowel Dis. 2010. PMID: 19637384 No abstract available.
Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease.
Siegel CA, Siegel LS, Hyams JS, Kugathasan S, Markowitz J, Rosh JR, Leleiko N, Mack DR, Crandall W, Evans J, Keljo DJ, Otley AR, Oliva-Hemker M, Farrior S, Langton CR, Wrobel IT, Wahbeh G, Quiros JA, Silber G, Bahar RJ, Sands BE, Dubinsky MC. Siegel CA, et al. Among authors: siegel ls. Inflamm Bowel Dis. 2011 Jan;17(1):30-8. doi: 10.1002/ibd.21386. Epub 2010 Sep 1. Inflamm Bowel Dis. 2011. PMID: 20812335 Free PMC article.
The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety.
Van Assche G, Lewis JD, Lichtenstein GR, Loftus EV, Ouyang Q, Panes J, Siegel CA, Sandborn WJ, Travis SP, Colombel JF. Van Assche G, et al. Among authors: siegel ca. Am J Gastroenterol. 2011 Sep;106(9):1594-602; quiz 1593, 1603. doi: 10.1038/ajg.2011.211. Epub 2011 Aug 16. Am J Gastroenterol. 2011. PMID: 21844919 Review.
Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groups.
Cheifetz AS, Melmed GY, Spiegel B, Talley J, Devlin SM, Raffals L, Irving PM, Jones J, Kaplan GG, Kozuch P, Sparrow M, Velayos F, Baidoo L, Bressler B, Siegel CA. Cheifetz AS, et al. Among authors: siegel ca. Inflamm Bowel Dis. 2012 Dec;18(12):2294-300. doi: 10.1002/ibd.22920. Epub 2012 Feb 15. Inflamm Bowel Dis. 2012. PMID: 22337359
IBS patients' willingness to take risks with medications.
Lacy BE, Everhart KK, Weiser KT, DeLee R, Strobel S, Siegel C, Crowell MD. Lacy BE, et al. Am J Gastroenterol. 2012 Jun;107(6):804-9. doi: 10.1038/ajg.2011.485. Am J Gastroenterol. 2012. PMID: 22664841
Do inflammatory bowel disease therapies cause cancer?
Mason M, Siegel CA. Mason M, et al. Among authors: siegel ca. Inflamm Bowel Dis. 2013 May;19(6):1306-21. doi: 10.1097/MIB.0b013e3182807618. Inflamm Bowel Dis. 2013. PMID: 23470503 Review.
220 results